Financhill
Buy
62

PASG Quote, Financials, Valuation and Earnings

Last price:
$10.85
Seasonality move :
-1.55%
Day range:
$10.49 - $11.03
52-week range:
$5.12 - $20.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.09x
Volume:
21.5K
Avg. volume:
46.7K
1-year change:
-17.71%
Market cap:
$33.9M
Revenue:
--
EPS (TTM):
-$9.75

Earnings Data

Next earnings date for PASG
Mar 03
2026
Most recent earnings per share
-$2.44
Beat by $0.53
(Nov 10/2025)
Consensus Estimate
-$2.97
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PASG Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/03/2026 Q4 -- -- -- -$2.80 --
11/10/2025 Q3 -- -- -$2.44 -$2.97 $0.53
08/12/2025 Q2 -- -- -$2.96 -$4.15 $1.19
05/13/2025 Q1 -- -- -$0.25 -$4.47 $4.22
03/04/2025 Q4 -- -- -$4.10 -$4.00 -$0.10
11/13/2024 Q3 $2M -- -$0.31 -$4.67 $4.35
08/08/2024 Q2 -- -- -$0.26 -$6.20 $5.94
05/14/2024 Q1 -- -- -$0.30 -$6.90 $6.60
03/04/2024 Q4 -- -- -$0.31 -$8.00 $7.70
11/13/2023 Q3 -- -- -$0.49 -- --
08/07/2023 Q2 -- -- -$0.44 -- --
05/11/2023 Q1 -- -- -$0.63 -- --
03/06/2023 Q4 -- -- -$0.50 -- --
11/10/2022 Q3 -- -- -$0.49 -- --
08/04/2022 Q2 -- -- -$0.73 -- --
05/16/2022 Q1 -- -- -$0.79 -- --
03/03/2022 Q4 -- -- -$0.95 -- --
11/04/2021 Q3 -- -- -$0.87 -- --
08/05/2021 Q2 -- -- -$0.90 -- --
05/05/2021 Q1 -- -- -$0.76 -- --
03/03/2021 Q4 -- -- -$0.85 -- --
11/10/2020 Q3 -- -- -$0.63 -- --
08/13/2020 Q2 -- -- -$0.60 -- --
05/11/2020 Q1 -- -- -$1.00 -- --
12/31/2019 Q4 -- -- -$0.29 -- --
09/30/2019 Q3 -- -- -$9.50 -- --
06/30/2019 Q2 -- -- -$0.29 -- --
03/31/2019 Q1 -- -- -$6.40 -- --
12/31/2018 Q4 -- -- -$0.13 -- --

Passage Bio, Inc. Earnings Questions

  • How Much did Passage Bio, Inc. Generate in Revenue Last Quarter?

    Passage Bio, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Passage Bio, Inc. Beat Earnings Last Quarter?

    Passage Bio, Inc. announced earnings per share of -$2.44 which represents a beat of analyst forecast a -$2.97 per share.

  • Is Passage Bio, Inc. Profitable?

    Passage Bio, Inc. reported -$200K that represents -$0.06 per share over the last quarter.

  • What is the Analyst Consensus for Passage Bio, Inc. EPS Next Year?

    Passage Bio, Inc.'s earnings are forecast to decrease from -$21.44 per share to -$16.50 per share next year representing a decrease of -47.92%.

  • When is Passage Bio, Inc.'s Earnings Date?

    Passage Bio, Inc.'s next earnings date is March 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 25

Galecto, Inc. [GLTO] is down 0% over the past day.

Sell
20
SMX alert for Dec 29

SMX (Security Matters) Plc [SMX] is down 9.8% over the past day.

Sell
11
CDNAF alert for Dec 25

Canadian Tire Corp. Ltd. [CDNAF] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock